Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Error processing in Huntington's disease.

Christian Beste1, Carsten Saft, Jürgen Andrich

  • 1Leibniz Research Centre for Working Environment and Human Factors, Dortmund, Germany. beste@ifado.de

Plos One
|December 22, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Virtual reality-based oculography detects internuclear ophthalmoplegia in multiple sclerosis and other neurological disorders.

Journal of neurology·2026
Same author

Challenges facing genetic diagnostics of Huntington's disease: an update.

Expert review of molecular diagnostics·2026
Same author

The DNA/RNA autophagy protein SIDT2 as a novel neuropathological hallmark in Huntington disease.

Brain pathology (Zurich, Switzerland)·2026
Same author

Loss-of-function variants in the CAPN1 activator CD99L2 cause X-linked spastic ataxia.

Nature communications·2026
Same author

Pridopidine in early-stage manifest Huntington's disease: a phase 3 trial.

Nature medicine·2025
Same author

Examination of Anti-Inflammatory Effects After Propionate Supplementation in the R6/2 Mouse Model of Huntington's Disease.

International journal of molecular sciences·2025
Same journal

Analysis of strength degradation of coal and rock masses and stability of mined areas under long term immersion environment.

PloS one·2026
Same journal

Biogenic Silver-Selenium nanocomposite with anticancer activity and potent efficacy against vancomycin-resistant Staphylococcus aureus.

PloS one·2026
Same journal

Preparation and physicochemical characterization of a biodegradable chitosan/carboxymethyl cellulose hydrogel synthesized in NaOH/urea medium.

PloS one·2026
Same journal

Action-guilt, survivor-guilt, and depression in combat-related PTSD.

PloS one·2026
Same journal

Explainable machine learning for predicting activities of daily living at discharge in stroke patients: A retrospective study using SHAP interpretability.

PloS one·2026
Same journal

Deep learning based two-way feature depiction model for brain tumor detection.

PloS one·2026
See all related articles

Huntington's disease patients exhibit reduced error negativity (Ne), indicating impaired performance monitoring. This cognitive marker is linked to the CAG-repeat expansion, suggesting its potential as a biomarker for this genetic disorder.

Area of Science:

  • Neuroscience
  • Genetics
  • Cognitive Science

Background:

  • Huntington's disease (HD) involves basal ganglia degeneration and dopaminergic alterations linked to CAG-repeat expansion.
  • The error negativity (Ne/ERN), a brain potential for performance monitoring, depends on the dopaminergic system and is reduced in Parkinson's Disease.
  • HD's dopaminergic deficit suggests a potential reduction in Ne, possibly linking motor dysfunction to impaired error processing.

Purpose of the Study:

  • To investigate error negativity (Ne) in Huntington's disease patients.
  • To explore the relationship between Ne and genetic factors, specifically CAG-repeat expansion, in HD.
  • To assess the potential of Ne as a biomarker for dopaminergic dysfunction in HD.

Main Methods:

  • Assessed error negativity (Ne) using a speeded reaction task.

Related Experiment Videos

  • Analyzed Ne in relation to genetic abnormalities, including CAG-repeat length.
  • Compared Ne findings in HD patients to known patterns in other neurological disorders.

    • Main Results:

    • Huntington's disease patients demonstrated a significant reduction in error negativity (Ne).
    • This Ne reduction suggests impaired error processing in individuals with HD.
    • A strong correlation was observed between Ne reduction and the extent of CAG-repeat expansion.

    Conclusions:

    • The reduced Ne in HD is likely a consequence of dopaminergic pathology, similar to findings in Parkinson's Disease.
    • Ne may serve as a valuable measure of striatal dopaminergic output integrity.
    • The link between Ne and CAG-repeat expansion highlights its potential as a gene-associated cognitive biomarker for Huntington's disease.